PPARG and diabetes mellitus: Our research uniquely employs molecular docking analyses to identify interactions between key phytoconstituentswith diabetes management targets like alpha‐amylase and PPAR‐γ, providing a fresh perspective on their hypoglycemic effects at the molecular level with integration with in vitro antidiabetic acitivity and antioxidant activity.